ERBB2 and breast cancer: Triple-negative breast cancer, which lacks expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her-2), is the most aggressive subtype of breast cancer and has a poor prognosis.